Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-14T05:05:20.589Z Has data issue: false hasContentIssue false
  • English
  • Français

Catatonia made complex

Published online by Cambridge University Press:  02 January 2018

Tom Clark
Tom Clark*
Affiliation:
University of Birmingham, Reaside Clinic, Birmingham B45 9BE
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
The Columns
Information
Psychiatric Bulletin , Volume 26 , Issue 7 , July 2002 , pp. 275
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 2002. The Royal College of Psychiatrists

Sir: Catatonia has been a poorly understood syndrome since psychodynamic theory struggled to explain its symptoms in the first half of the past century. The persistence of the nosologic confusion surrounding catatonia, malignant catatonia and neuroleptic malignant syndrome (NMS) is well illustrated by Carey et al's confused and uncertain case study (Psychiatric Bulletin, February 2002, 26, 68-70).

Did their patient have ‘no history of catatonia’ or did he suffer from ‘persistent stereotypies, mannerisms… dyskinesia and… dystonia’? Both statements cannot be true! It is unsurprising that in such a patient, with a possible history of encephalitis, the administration of high dose, high potency neuroleptics precipitated the malignant syndrome. This is a well-recognised clinical scenario. The association of catatonia with general medical conditions was emphasised by Kahlbaum in 1874 and has been reviewed in detail more recently (Reference Philbrick and RummansPhilbrick & Rummans, 1994; Reference Clark and RickardsClark & Rickards, 1999).

The important points to remember are:

  1. (a) catatonia may be simple (motor symptoms only) or malignant (motor symptoms together with hyperthermia or autonomic instability)

  2. (b) neuroleptic (and some other) medications may exacerbate simple catatonia and precipitate malignant catatonia, in which case it may be termed the NMS

  3. (c) the most effective treatments for the catatonic syndrome are benzo-diazepines or electroconvulsive therapy.

A fuller, clinically orientated review, including a suggested management plan, has been provided by Clark and Rickards (Reference Clark and Rickards1999), while other authors have usefully considered the nosologic and dimensional status of the syndrome (for example, Reference Mann, Caroff and BleierMann et al, 1986; Reference Singerman and RahejaSingerman & Raheja, 1994; Reference FinkFink, 1996). It is unfortunate that Carey et al's discussion fails to aid understanding of a condition that is often iatrogenic and, as they point out, occasionally fatal.

References

Clark, T. & Rickards, H. (1999) Catatonia 2: Diagnosis, Management and Prognosis. Hospital Medicine, 60(11), 812–814.Google Scholar
Fink, M. (1996) Neuroleptic malignant syndrome and catatonia: one syndrome or two? Biological Psychiatry, 39, 1–4.CrossRefGoogle ScholarPubMed
Mann, S. C., Caroff, S. F., Bleier, H. R., et al (1986) Lethal catatonia. American Journal of Psychiatry, 143, 1374–1381.Google ScholarPubMed
Philbrick, K. L. & Rummans, T. A. (1994) Malignant catatonia. Journal of Neuropsychiatry, 6(1), 1–13.Google Scholar
Singerman, B. & Raheja, R. (1994) Malignant catatonia – a continuing reality. Annals of Clinical Psychiatry, 6, 259–266.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.